Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Intraperitoneal Chemotherapy in Gastric Cancer (Guided by Peritoneal DNA)
NCT05497739Phase 2Unknown
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Jun 2022
- Primary completion
- Jun 2024
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluorouracil, nab-paclitaxel, cisplatin, aldesleukin in gastric cancer (GC), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
fluorouracilnab-paclitaxelcisplatinaldesleukin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT05497739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05497739.